BEIJING, 28 aug. 2024 /PRNewswire/ — Jenscare Scientific Co. (“Jenscare” of het “Bedrijf”) (HKEX: 9877), een innovatief bedrijf in medische hulpmiddelen dat zich toelegt op de interventionele behandeling van structurele hartziekten met TTVR-doorbraken, heeft de tussentijdse resultaten…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.